According to these parameters ESR1, EGFR, and BCL2 are deemed core targets within the PPI network, highlighting their significance in potential therapeutic interventions which play an important role in the treatment of tongue cancer (Fig. 12) (Table 3). The gene discussed is BCL2; the disease is tongue cancer.